List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2012-21
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2012-16
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2016-21
Table 4: South Africa generics market value: $ million, 2012-16
Table 5: South Africa generics market volume: % of total pharma volume, 2012-16
Table 6: South Africa generics market geography segmentation: $ million, 2016
Table 7: South Africa generics market value forecast: $ million, 2016-21
Table 8: South Africa generics market volume forecast: % of total pharma volume, 2016-21
Table 61: South Africa size of population (million), 2012-16
Table 62: South Africa gdp (constant 2005 prices, $ billion), 2012-16
Table 63: South Africa gdp (current prices, $ billion), 2012-16
Table 64: South Africa inflation, 2012-16
Table 65: South Africa consumer price index (absolute), 2012-16
Table 66: South Africa exchange rate, 2012-16
Table 9: Brazil generics market value: $ million, 2012-16
Table 10: Brazil generics market volume: % of total pharma volume, 2012-16
Table 11: Brazil generics market geography segmentation: $ million, 2016
Table 12: Brazil generics market value forecast: $ million, 2016-21
Table 13: Brazil generics market volume forecast: % of total pharma volume, 2016-21
Table 14: Brazil size of population (million), 2012-16
Table 15: Brazil gdp (constant 2005 prices, $ billion), 2012-16
Table 16: Brazil gdp (current prices, $ billion), 2012-16
Table 17: Brazil inflation, 2012-16
Table 18: Brazil consumer price index (absolute), 2012-16
Table 19: Brazil exchange rate, 2012-16
Table 20: China generics market value: $ billion, 2012-16
Table 21: China generics market volume: % of total pharma volume, 2012-16
Table 22: China generics market geography segmentation: $ billion, 2016
Table 23: China generics market value forecast: $ billion, 2016-21
Table 24: China generics market volume forecast: % of total pharma volume, 2016-21
Table 25: China size of population (million), 2012-16
Table 26: China gdp (constant 2005 prices, $ billion), 2012-16
Table 27: China gdp (current prices, $ billion), 2012-16
Table 28: China inflation, 2012-16
Table 29: China consumer price index (absolute), 2012-16
Table 30: China exchange rate, 2012-16
Table 31: India generics market value: $ million, 2012-16
Table 32: India generics market volume: % of total pharma volume, 2012-16
Table 33: India generics market geography segmentation: $ million, 2016
Table 34: India generics market value forecast: $ million, 2016-21
Table 35: India generics market volume forecast: % of total pharma volume, 2016-21
Table 36: India size of population (million), 2012-16
Table 37: India gdp (constant 2005 prices, $ billion), 2012-16
Table 38: India gdp (current prices, $ billion), 2012-16
Table 39: India inflation, 2012-16
Table 40: India consumer price index (absolute), 2012-16
Table 41: India exchange rate, 2012-16
Table 42: Mexico generics market value: $ million, 2012-16
Table 43: Mexico generics market volume: % of total pharma volume, 2012-16
Table 44: Mexico generics market geography segmentation: $ million, 2016
Table 45: Mexico generics market value forecast: $ million, 2016-21
Table 46: Mexico generics market volume forecast: % of total pharma volume, 2016-21
Table 47: Mexico size of population (million), 2012-16
Table 48: Mexico gdp (constant 2005 prices, $ billion), 2012-16
Table 49: Mexico gdp (current prices, $ billion), 2012-16
Table 50: Mexico inflation, 2012-16
Table 51: Mexico consumer price index (absolute), 2012-16
Table 52: Mexico exchange rate, 2012-16
Table 53: Adcock Ingram Holdings Ltd: key facts
Table 54: Adcock Ingram Holdings Ltd: key financials ($)
Table 55: Adcock Ingram Holdings Ltd: key financials (ZAR)
Table 56: Adcock Ingram Holdings Ltd: key financial ratios
Table 57: Aspen Pharmacare Holdings Ltd: key facts
Table 58: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 59: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 60: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 67: Ache Laboratorios Farmaceuticos SA: key facts
Table 68: EMS SA: key facts
Table 69: Sanofi SA: key facts
Table 70: Sanofi SA: key financials ($)
Table 71: Sanofi SA: key financials (€)
Table 72: Sanofi SA: key financial ratios
Table 73: Eurofarma Laboratorios SA: key facts
Table 74: China Grand Pharmaceutical and Healthcare Holdings Limited: key facts
Table 75: China Grand Pharmaceutical and Healthcare Holdings Limited: key financials ($)
Table 76: China Grand Pharmaceutical and Healthcare Holdings Limited: key financials (CNY)
Table 77: China Grand Pharmaceutical and Healthcare Holdings Limited: key financial ratios
Table 78: Mylan N.V.: key facts
Table 79: Mylan N.V.: key financials ($)
Table 80: Mylan N.V.: key financial ratios
Table 81: Aurobindo Pharma Limited: key facts
Table 82: Aurobindo Pharma Limited: key financials ($)
Table 83: Aurobindo Pharma Limited: key financials (A$)
Table 84: Aurobindo Pharma Limited: key financial ratios
Table 85: Cipla Limited: key facts
Table 86: Cipla Limited: key financials ($)
Table 87: Cipla Limited: key financials (Rs.)
Table 88: Cipla Limited: key financial ratios
Table 89: Lupin Ltd: key facts
Table 90: Lupin Ltd: key financials ($)
Table 91: Lupin Ltd: key financials (Rs.)
Table 92: Lupin Ltd: key financial ratios
Table 93: Sun Pharmaceutical Industries Ltd: key facts
Table 94: Sun Pharmaceutical Industries Ltd: key financials ($)
Table 95: Sun Pharmaceutical Industries Ltd: key financials (Rs.)
Table 96: Sun Pharmaceutical Industries Ltd: key financial ratios
Table 97: Apotex, Inc.: key facts
Table 98: Novartis AG: key facts
Table 99: Novartis AG: key financials ($)
Table 100: Novartis AG: key financial ratios
Table 101: Teva Pharmaceutical Industries Limited: key facts
Table 102: Teva Pharmaceutical Industries Limited: key financials ($)
Table 103: Teva Pharmaceutical Industries Limited: key financial ratios